To examine if this synthetic C2ORF40MPF could function equivalently as C2ORF40 in breast cancer cells, we assessed its inhibitory ability on cell growth using MTT assay, and used non-treatment and the synthesized scrambled C2ORF40 mimic peptide (ScrC2ORF40) as controls. This evidence concerns the gene ECRG4 and breast cancer.